BioWorld

Dec. 28, 2005

View Archived Issues

Pfizer Buying Into Perlegen's Pharmacogenomics Platform

Taking 12 percent ownership in the firm, Pfizer Inc. invested $50 million in personalized medicine company Perlegen Sciences Inc. (BioWorld Today) Read More

Tibotec Submits NDA: New Protease Inhibitor For HIV

Read More

Targanta Adding Antibiotic; InterMune Narrows Pipeline

Read More

As Panvac Phase III Finishes, Therion Secures $50M Credit

Read More

Other News To Note

Read More